Forecasted

Critical Path Public Private Partnerships Clinical Trials Optional

Federal funding opportunity FOR-FD-24-012 from Food and Drug Administration.

This forecast was posted November 30, 2023, with no update recorded since. A forecast is an agency’s statement of planned funding rather than an open opportunity, and this one has not moved in over a year. Agencies do not always withdraw plans they have dropped, so confirm it on the official listing at Grants.gov before building plans around it.

View forecast on Grants.gov →Forecasted — not yet open · no update since it was posted

Posted: November 30, 2023
Closes: See announcement
Award ceiling: $20,000,000
Award floor: $20,000,000
Expected awards: 1
Cost sharing: No
Instrument: Cooperative Agreement, Grant
Assistance listing: 93.103
Category: Agriculture, Consumer Protection, Food and Nutrition

Program funding history

Awards made under Assistance Listing 93.103 across FY2025–FY2027, from public federal spending records.

FY2025 obligated: $213M
FY2026 obligated: $215.3M
FY2027 (to date) obligated: $0
Awards in window: 849

Top recipients: The Critical Path Institute, National Environmental Health Association, Association of Food & Drug Officials, Yale Univ, Food & Agriculture, California Department of

Source: USAspending.gov · refreshed October 2026 · Program page: awards, recipients and the opportunities under this listing →

Synopsis

The FDA seeks an application to continue to maintain, manage existing consortia groups convened and established by the Critical Path Institute. This is a renewal of the cooperative agreement #5U18FD005320 as part of the Critical Path Initiative. This is in support of Critical Path Initiative introduced in Section 566 of the Federal Food, Drug, and Cosmetic Act. This includes developing innovative, collaborative projects in research, education, and outreach for fostering drug product innovation, enabling the acceleration of development, manufacturing, and translational therapeutics, enhancing safety, efficacy, quality, and performance. This funding opportunity will provide support, depending on availability of FDA funding.

Who can apply

Others (see text field entitled "Additional Information on Eligibility" for clarification)

Critical Path Institute

How to apply

Applications go through the official government listing. Grants Radar links you straight to the source — applying is free.

View on Grants.gov

Agency contact: Terrin Brown Grantor · [email protected] · (240) 402-7610

New to federal funding? How to read an announcement · Who can apply · How grants work

Tell me when this program posts again

One email the morning after this program opens for applications — under this number or a new one — and one more about a week before it closes (the next morning, if it is already closer than that). That is all this sends — it is not a newsletter signup.

Stored once per grant, used only for this watch’s emails; every one carries a one-click unsubscribe. Privacy

Get grants like this every Tuesday — free

One email a week: the biggest new federal grants and what’s closing soon — the same list for everyone. Unsubscribe any time.

No spam, ever. Privacy

Similar grants

Center for Research on Complex Generics (U18) Clinical Trials Optional
FOR-FD-25-004 · Food and Drug Administration
REACHing Communities (REACH) Consortium (U01) Clinical Trials Optional
FOR-FD-25-012 · Food and Drug Administration
Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed
PAR-25-003 · Food and Drug Administration · closes April 1, 2027
Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed
FOR-FD-24-001 · Food and Drug Administration
Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional
FOR-FD-24-002 · Food and Drug Administration
Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional
FOR-FD-24-005 · Food and Drug Administration

Same-day alerts, matched to you

The free digest is weekly — the same list for everyone. Members get every open federal grant scored to their organization — and an alert the day a real match posts: we read every new posting the day it opens. Free for 30 days, then $29/mo. Card required, cancel any time before day 31.

Not ready for a subscription? A one-time Fit Report — $29 — scores every open federal grant to your organization once, by email within one business day.

See pricing